KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $670.0 million.

  • Boston Scientific's Consolidated Net Income rose 1921.71% to $670.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 5671.72%. This contributed to the annual value of $2.9 billion for FY2025, which is 5666.31% up from last year.
  • Per Boston Scientific's latest filing, its Consolidated Net Income stood at $670.0 million for Q4 2025, which was up 1921.71% from $756.0 million recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Consolidated Net Income ranged from a high of $795.0 million in Q2 2025 and a low of $93.0 million during Q4 2021
  • Its 5-year average for Consolidated Net Income is $403.5 million, with a median of $380.0 million in 2021.
  • In the last 5 years, Boston Scientific's Consolidated Net Income skyrocketed by 331000.0% in 2021 and then plummeted by 6744.87% in 2022.
  • Boston Scientific's Consolidated Net Income (Quarter) stood at $93.0 million in 2021, then skyrocketed by 51.61% to $141.0 million in 2022, then surged by 257.45% to $504.0 million in 2023, then grew by 11.51% to $562.0 million in 2024, then increased by 19.22% to $670.0 million in 2025.
  • Its Consolidated Net Income stands at $670.0 million for Q4 2025, versus $756.0 million for Q3 2025 and $795.0 million for Q2 2025.